Physostigmine increases the dose of propofol required to induce anaesthesia

Canadian Journal of Anaesthesia

Volumn 44, Issue 11, 1997, Pages 1148-1151

  Fassoulaki, Argyro ^a,c   Sarantopoulos, Constantine ^b   Derveniotis, Ch ^c  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ISOFLURANE; METOCLOPRAMIDE; MIVACURIUM; MUSCLE RELAXANT AGENT; NITROUS OXIDE; ONDANSETRON; OPIATE; PHYSOSTIGMINE; PROPOFOL; ROCURONIUM; SEVOFLURANE;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BREAST SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL ANESTHESIA; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031450338     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03013335     Document Type: Article

References (14)

1. Snir-Mor I, Weinstock M, Davidson JT, Bahar M. Physostigmine antagonizes morphine-induced respiratory depression in human subjects. Anesthesiology 1983; 59: 6-9.
2. Caldwell CB, Gross JB. Physostigmine reversal of midazolam-induced sedation. Anesthesiology 1982; 57: 125-7.
3. Toro-Matos A, Rendon-Platas AM, Avila-Valdez E, Villamal-Guzman RA. Physostigmine antagonizes ketamine. Anesth Analg 1980; 59: 764-7.
4. Fassoulaki A, Farinotti R, Servin F, Desmonts JM. Chronic alcoholism increases the induction dose of propofol in humans. Anesth Analg 1993; 77: 553-6.
5. Lerman J. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996; 43: 184-91.
6. Mimura M, Namiki A, Kishy R, Ikeda T, Miyake H, Iwasaki H. Central cholinergic action produces antagonism to ketamine anesthesia. Acta Anaesthesiol Scand 1992; 36: 460-2.
7. Durieux ME. Inhibition by ketamine of muscarinic acetylcholine receptor function. Anesth Analg 1995; 81: 57-62.
8. Collins GGS. Effects of the anaesthetic 2,6-diisopropylphenol on synaptic transmission in the rat olfactory cortex slice. Br J Pharmacol 1988; 95: 939-49.
9. Peduto VA, Concas A, Santoro G, Biggio G, Gessa GL. Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology 1991; 75; 1000-9.
10. Simpson VJ, Blednov Y. Propofol produces differences in behavior but not chloride channel function between selected lines of mice. Anesth Analg 1996; 82: 327-31.
11. Fassoulaki A, Sarantopoulos C, Papilas K. Flumazenil reduces die duration of thiopentone but not of propofol anaesthesia in humans. Can J Anaesth 1993; 40: 10-2.
12. Durieux ME. Muscarinic signaling in the central nervous system. Anesthesiology 1996; 84: 173-89.
13. Flood P, Ramirez-Latorre J, Role L. α4ß2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but α7-type nicotinic acetyicholine receptors are unaffected. Anesthesiology 1997; 86: 859-65.
14. Violet JM, Downie DL, Nakisa RC, Lieb WR, Franks NP. Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics. Anesthesiology 1997; 86: 866-74.